Changchun BCHT Biotechnology Co.

SHSE:688276 Stock Report

Market Cap: CN¥9.8b

Changchun BCHT Biotechnology Past Earnings Performance

Past criteria checks 5/6

Changchun BCHT Biotechnology has been growing earnings at an average annual rate of 10.2%, while the Biotechs industry saw earnings growing at 7.6% annually. Revenues have been growing at an average rate of 9.2% per year. Changchun BCHT Biotechnology's return on equity is 9.9%, and it has net margins of 25.8%.

Key information

10.2%

Earnings growth rate

6.6%

EPS growth rate

Biotechs Industry Growth11.3%
Revenue growth rate9.2%
Return on equity9.9%
Net Margin25.8%
Next Earnings Update21 Apr 2025

Recent past performance updates

We Think That There Are Issues Underlying Changchun BCHT Biotechnology's (SHSE:688276) Earnings

Mar 30
We Think That There Are Issues Underlying Changchun BCHT Biotechnology's (SHSE:688276) Earnings

Recent updates

Changchun BCHT Biotechnology (SHSE:688276) Seems To Use Debt Quite Sensibly

Jan 03
Changchun BCHT Biotechnology (SHSE:688276) Seems To Use Debt Quite Sensibly

Market Might Still Lack Some Conviction On Changchun BCHT Biotechnology Co. (SHSE:688276) Even After 36% Share Price Boost

Oct 07
Market Might Still Lack Some Conviction On Changchun BCHT Biotechnology Co. (SHSE:688276) Even After 36% Share Price Boost

Analysts Just Slashed Their Changchun BCHT Biotechnology Co. (SHSE:688276) EPS Numbers

Aug 22
Analysts Just Slashed Their Changchun BCHT Biotechnology Co. (SHSE:688276) EPS Numbers

Changchun BCHT Biotechnology Co. (SHSE:688276) Doing What It Can To Lift Shares

Jul 28
Changchun BCHT Biotechnology Co. (SHSE:688276) Doing What It Can To Lift Shares

Is Changchun BCHT Biotechnology (SHSE:688276) Using Too Much Debt?

Jun 19
Is Changchun BCHT Biotechnology (SHSE:688276) Using Too Much Debt?

Changchun BCHT Biotechnology Co. (SHSE:688276) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

Apr 16
Changchun BCHT Biotechnology Co. (SHSE:688276) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

We Think That There Are Issues Underlying Changchun BCHT Biotechnology's (SHSE:688276) Earnings

Mar 30
We Think That There Are Issues Underlying Changchun BCHT Biotechnology's (SHSE:688276) Earnings

Revenue & Expenses Breakdown

How Changchun BCHT Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SHSE:688276 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,608414745178
30 Jun 241,883527867197
31 Mar 241,916543889212
31 Dec 231,825501861198
30 Sep 231,449301733171
30 Jun 231,190219640144
31 Mar 231,113183611139
31 Dec 221,071182586134
30 Sep 221,123222563137
30 Jun 221,061179538159
31 Mar 221,093205522167
31 Dec 211,202244567157
30 Sep 211,304309640141
30 Jun 211,424377681123
31 Mar 211,48942471892
31 Dec 201,44141868993
31 Dec 1997622151865
31 Dec 181,01912867662

Quality Earnings: 688276 has high quality earnings.

Growing Profit Margin: 688276's current net profit margins (25.8%) are higher than last year (20.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 688276's earnings have grown by 10.2% per year over the past 5 years.

Accelerating Growth: 688276's earnings growth over the past year (37.7%) exceeds its 5-year average (10.2% per year).

Earnings vs Industry: 688276 earnings growth over the past year (37.7%) exceeded the Biotechs industry 1.3%.

Return on Equity

High ROE: 688276's Return on Equity (9.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 07:11
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Changchun BCHT Biotechnology Co. is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hangci ZhengChina International Capital Corporation Limited
Yizheng YangChina International Capital Corporation Limited
Sophia ZhangChina Stock Investment Research Co. Ltd. (GZ500..com)